High Tech Pharm Co (106190.KQ) Stock Price

High Tech Pharm Co Price

CLOSED
10,000.00
​
Market closed

Over the last 19 years High Tech Pharm Co grew revenue by 7.0% annually, reaching 70.18 B KRW. Earnings per share have grown at 9.3% per year over the last 19 years. For High Tech Pharm Co, the net margin of 16.4% is up versus -1.7% a few years ago. At today's price the dividend yield works out to roughly 1.00%. The payout ratio is around 9% of earnings. The dividend has grown at 5.2% per year over the past 15 years.

High Tech Pharm Co stock price

Access this data via the Eulerpool API

High Tech Pharm Co business model & stock analysis

HIGH TECH PHARM Co., Ltd. engages in the manufacture and sale of raw materials for injectable antibiotic products. The company is headquartered in Chungju, Chungcheongbuk-Do and currently employs 120 full-time employees. The company went IPO on 2010-07-28. CO., LTD. is a Korea-based company mainly engaged in the manufacture of antibiotic pharmaceutical ingredients for injections. The firm's products include sterile imipenem, sterile cilastatin sodium, sterile blended imipenem and cilastatin sodium, injectable sterile meropenem, injectable sterile panipenem, faropenem and others. The firm distributes its products within domestic market and to overseas markets.

Frequently asked questions about High Tech Pharm Co

Converted at the current exchange rate, the High Tech Pharm Co share trades at 6.65 EUR (10,000.00 KRW).

The revenue cannot currently be calculated for High Tech Pharm Co.

The profit cannot currently be calculated for High Tech Pharm Co.

The P/E ratio cannot be calculated for High Tech Pharm Co at the moment.

The P/S cannot be calculated for High Tech Pharm Co currently.

The Eulerpool Quality Score for High Tech Pharm Co is 3/10.

The ISIN of High Tech Pharm Co is KR7106190002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of High Tech Pharm Co is 106190.KQ. The ticker symbol is used to trade High Tech Pharm Co shares on the stock exchange.

Fair ValueTerminal
8,200.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
584.86 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website htpharm.com
Country
South Korea
Currency
KRW
Initial public offering
Jul 28, 2010
ISIN
KR7106190002
Cusip
Y3187B107
Market capitalization
106.33 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
7.60
P/B Ratio
0.81
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
8.78 %
Dividend
Dividend yield
1.00 %
Payout Ratio
8.85 %
Dividend growth Ø5Y
24.57 %
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Oct 9, 2026, 7:26 AM

High Tech Pharm Co Peer Group

High Tech Pharm Co FIGI

106190:KS · BBG000R2ZYP5106190:KQ · BBG000R2ZZ90